The UVA Center for Diabetes Technology seeks adults 18 years or older who have Type 1 Diabetes and is currently using a Tandem Control-IQ (CIQ) insulin pump to participate in a research study.
The purpose of this study is to assess the safety of a weekly adjustment to your insulin parameters using a table that developed by the study team. The goal of these insulin parameter adjustments is aimed at reducing hypoglycemic and hyperglycemic events that you may experience. During the 6 week study, you will use your personal CIQ with your usual insulin parameters for 3 weeks, and you will use your personal CIQ with insulin parameters generated by the study team for 3 weeks.
You may be eligible for this study if:
• Age =18 years of age
• Clinical diagnosis, based on investigator assessment, of type 1 diabetes for at least 1 year
• Currently using insulin for at least six months
• Currently using the CIQ insulin pump
Study-related Hemoglobin A1c, pregnancy test, and physical exam (if one hasn’t been done in the last 12 months) provided free of charge.
Compensation for study completion is $400. You will be provided continuous glucose monitoring supplies to use during the study.